BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15057898)

  • 1. Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach.
    Neo SY; Leow CK; Vega VB; Long PM; Islam AF; Lai PB; Liu ET; Ren EC
    Hepatology; 2004 Apr; 39(4):944-53. PubMed ID: 15057898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feature genes of hepatitis B virus-positive hepatocellular carcinoma, established by its molecular discrimination approach using prediction analysis of microarray.
    Kim BY; Lee JG; Park S; Ahn JY; Ju YJ; Chung JH; Han CJ; Jeong SH; Yeom YI; Kim S; Lee YS; Kim CM; Eom EM; Lee DH; Choi KY; Cho MH; Suh KS; Choi DW; Lee KH
    Biochim Biophys Acta; 2004 Dec; 1739(1):50-61. PubMed ID: 15607117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random gene sets in predicting survival of patients with hepatocellular carcinoma.
    Itzel T; Spang R; Maass T; Munker S; Roessler S; Ebert MP; Schlitt HJ; Herr W; Evert M; Teufel A
    J Mol Med (Berl); 2019 Jun; 97(6):879-888. PubMed ID: 31001651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 5. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 7. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
    Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
    Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative and integrative functional genomics of HCC.
    Lee JS; Thorgeirsson SS
    Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.
    Xu XR; Huang J; Xu ZG; Qian BZ; Zhu ZD; Yan Q; Cai T; Zhang X; Xiao HS; Qu J; Liu F; Huang QH; Cheng ZH; Li NG; Du JJ; Hu W; Shen KT; Lu G; Fu G; Zhong M; Xu SH; Gu WY; Huang W; Zhao XT; Hu GX; Gu JR; Chen Z; Han ZG
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15089-94. PubMed ID: 11752456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles.
    Jiang M; Zeng Q; Dai S; Liang H; Dai F; Xie X; Lu K; Gao C
    Mol Med Rep; 2017 Jan; 15(1):380-386. PubMed ID: 27959423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
    Kim BY; Suh KS; Lee JG; Woo SR; Park IC; Park SH; Han CJ; Kim SB; Jeong SH; Yeom YI; Yang SJ; Kim CM; Cho SJ; Yoo YD; Cho MH; Jang JJ; Choi DW; Lee KH
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.
    Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N
    Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients.
    Zhang X; Yin S; Ma K
    J Int Med Res; 2020 Jun; 48(6):300060520932112. PubMed ID: 32567431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW
    Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
    Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
    Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis.
    Sun Y; Li W; Shen S; Yang X; Lu B; Zhang X; Lu P; Shen Y; Ji J
    J Transl Med; 2019 Nov; 17(1):390. PubMed ID: 31771612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.